To view or add a comment, sign in 253 followers
The conversation about GLP-1 medications and muscle often begins with a frightening statistic: A significant percentage of the weight lost may be lean mass. That deserves attention
Patients experience significant weight loss, typically 10-15% of body weight. A1C levels drop, reducing long-term diabetes-related risks. Lower cholesterol and blood pressure levels, improving cardiovascular health
Myth #4: Youll Regain All the Weight Once You Stop The Truth: Weight regain can happen if old habits return, but thats true of any weight loss method
Early-access pricing reserved for waitlist members only, kept lower than open-market rates
During shortages of Wegovy, Ozempic, Mounjaro, and Zepbound, the FDA exercised temporary enforcement discretion , allowing compounding pharmacies to help meet patient demand. Once manufacturing stabilized: Semaglutide injection products were removed from the FDA Drug Shortage List Tirzepatide injection products were formally declared resolved Compounding reverted to pre-shortage federal and state limits Broad, shortage-based compounding is no longer allowed in 2026
